Dr. Reddy’s Laboratories (NYSE:RDY) has been busy launching generics and the recent U.S. launch of a generic version of Novatis AG’s (NYSE:NVS) over-the-counter (OTC) drug, Prevacid, was the second one in less than a week. The U.S. Food and Drug Administration (FDA) approved the Abbreviated New Drug Application (ANDA) for 15 mg formulation of the generic drug.
Prevacid is approved for the treatment of acid reflux disease and heartburn. According to the data of SymphonyIRI InfoScan Reviews, … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here